Fernandez, Maria Victoria
Liu, Menghan
Beric, Aleksandra http://orcid.org/0000-0002-9351-585X
Johnson, Matt
Cetin, Arda http://orcid.org/0000-0003-4297-5984
Patel, Maulik
Budde, John http://orcid.org/0000-0001-7778-7276
Kohlfeld, Pat http://orcid.org/0009-0004-9206-8244
Bergmann, Kristy
Lowery, Joseph
Flynn, Allison
Brock, William
Sanchez Montejo, Brenda
Gentsch, Jen
Sykora, Nicholas
Norton, Joanne
Gentsch, Jen
Valdez, Olga
Gorijala, Priyanka
Sanford, Jessie
Sun, Yichen
Wang, Ciyang
Western, Dan http://orcid.org/0000-0003-3725-9553
Timsina, Jigyasha
Mangetti Goncalves, Tassia
Do, Anh N.
Sung, Yun Ju
Zhao, Guoyan http://orcid.org/0000-0001-5615-6774
Morris, John C.
Moulder, Krista
Holtzman, David M. http://orcid.org/0000-0002-3400-0856
Bateman, Randall J. http://orcid.org/0000-0002-7729-1702
Karch, Celeste http://orcid.org/0000-0002-6854-5547
Hassenstab, Jason
Xiong, Chengjie
Schindler, Suzanne E. http://orcid.org/0000-0002-1680-1465
Balls-Berry, Joyce
Benzinger, Tammie L. S.
Perrin, Richard J. http://orcid.org/0000-0002-3443-7716
Denny, Andrea
Snider, B. Joy
Stark, Susan L.
Ibanez, Laura
Cruchaga, Carlos http://orcid.org/0000-0002-0276-2899
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | Center for Scientific Review (P30AG066444)
Article History
Received: 24 January 2024
Accepted: 6 June 2024
First Online: 12 July 2024
Competing interests
: DMH has equity and is on the scientific advisory board of C2N Diagnostics. DMH is on the scientific advisory board of Denali, Genentech, and Cajal Neuroscience and consults for Asteroid. RB has received funding from NIH, Alzheimer’s Association, Biogen, AbbVie, Bristol Meyer Squibbs, Novartis, and EISAI. RB has equity and is on the scientific advisory board of C2N Diagnostics. SES has served on advisory boards and consulted on biomarker testing for Eisai, and she has received speaker fees from Eli Lilly. TLSB received research funding from Siemens and is an investigator on clinical trials and studies of AD with partial support from Eisai, Lilly, Roche, Janssen, and Biogen. TLSB is a consultant to Eisai. CC has received research support from: GSK and Eisai. CC is a member of the advisory board of Circular Genomics and owns stocks. CC is a member of the advisory board of ADmit.